alpha phellandrene has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acha, BT; Almeida, FRC; Dias, WA; Dittz, D; Ferreira, PMP; Gomes, LDS; Leal, BS; Lopes, EM; Pinheiro-Neto, FR; Reis Filho, ACD; Rodrigues, DCDN; Silva, JDN | 1 |
| Bezerra, DP; Bomfim, LM; Campos, AF; Costa, EV; Dias, RB; Menezes, LR; Nascimento, MP; Neto, AF; Rocha, CA; Rodrigues, AC; Silva, LC; Soares, MB | 1 |
2 other study(ies) available for alpha phellandrene and B16 Melanoma
| Article | Year |
|---|---|
α-Phellandrene exhibits antinociceptive and tumor-reducing effects in a mouse model of oncologic pain.
Topics: Analgesics; Animals; Antineoplastic Agents; Cancer Pain; Cell Line, Tumor; Cell Proliferation; Cyclohexane Monoterpenes; Cytokines; Female; Glutathione; Inflammation Mediators; Lipid Peroxidation; Melanoma, Experimental; Mice; Pain Threshold; Sarcoma 180; Tumor Burden; Tumor Cells, Cultured | 2021 |
Antitumour Activity of the Microencapsulation of Annona vepretorum Essential Oil.
Topics: Acyclic Monoterpenes; Adult; Alkenes; Animals; Annona; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Bicyclic Monoterpenes; Cell Line, Tumor; Cyclohexane Monoterpenes; Cyclohexanones; Disease Models, Animal; Drug Compounding; Gas Chromatography-Mass Spectrometry; Hep G2 Cells; Humans; Inhibitory Concentration 50; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Monoterpenes; Oils, Volatile; Plant Leaves; Sesquiterpenes; Sesquiterpenes, Germacrane; Terpenes; Young Adult | 2016 |